Research on the role of neuroinflammation in AD started with the identification of a rare coding variant in the TREM2 (triggering receptor expressed on myeloid cells 2) gene that encoded an immunoreceptor tyrosine-based activation motif-containing cell surface receptor that increased the risk for developing AD four to five-fold [151]. Here, CD177 is linked to Alzheimer disease.